C3 - Supporting “smart” seniors

Auditorium 2

Organised by the FIP YPG in collaboration with FIP’s Community Pharmacy Section & SIG on Pharmacy Practice Research

Chairs

Daragh Connolly, Irish Pharmacy Union, Ireland and Victoria García-Cárdenas, FIP Pharmacy Practice Research Special Interest Group, Australia

Introduction

This session focuses on the use of healthcare applications for the elderly generation and how pharmacists can be promoters for the safe and effective use of healthcare apps in an ageing population. Mobile devices, especially smartphones, have revolutionized people’s lives, including the way they seek medical information. The impact of mHealth apps can be enormous on many important health-related domains, including chronic disease management, mental health, and patient education and empowerment. For the older generation, one obvious limitation is that technologies have not been developed with this group in mind. In order to handle the change in demography and make a shift from treatment to prevention, mHealth systems need to be developed based on the needs and preferences of older adults so as to empower them to stay independent and mobile for longer.

Implementation of mHealth technologies may lead to a shift in control of the health service from the clinician to the people, which implies new roles for health care personnel, and also opens up opportunities for new types and modes of delivery of interventions. Pharmacists, as the most accessible healthcare by some countries, contribute to the safe use of mobile health by patients. When connected to cloud-based platforms, these technologies allow pharmacists to communicate with patients to clarify their understanding of conditions, complex drug regimens, and potential side effects. Combining the pharmacist with mHealth can help reduce healthcare costs and improve the patient experience, by allowing remote interaction with the pharmacist. Patient access to real-time medication lists can help both patient and pharmacist improve medication-related outcomes and patient’s adherence for the medications.

 

Programme

  1. How elderly perceived the use of healthcare apps
    Sarah Dineen-Griffin, University of Technology Sydney, Australia
  2. What is the impact of healthcare apps in the market for the ageing population?
    Inma Riu, Saludability, Spain
  3. Pharmacists as partners of patients in technology innovation: From theory to practice
    Tiago Costa, Unidade de Saúde da Ilha de São Miguel, Portugal

Learning Objectives

At the end of this session, participants will be able to:

  1. Explain how elders perceive healthcare apps as promoters of their health

  2. Outline the main limitations and difficulties elders encounter when using healthcare apps

  3. Identify the types of healthcare apps available in the market which can be used by the ageing population

  4. Prepare and plan the role of pharmacists as promoters of safe and useful use of healthcare apps in an ageing population

Type of session: Knowledge-based